20,184
Participants
Start Date
September 25, 2020
Primary Completion Date
May 31, 2023
Study Completion Date
June 1, 2023
Population-level screening
"The study intervention involves having patients complete a familial cancer risk assessment survey. Those who are found to be at high risk will be offered genetic testing for a panel of hereditary cancers. A previvor plan will be created to assist patients and their providers in completing the appropriate follow-up for those with a mutation identified."
Billings Clinic, Billings
MultiCare Health System, Tacoma
National Cancer Institute (NCI)
NIH
University of Washington
OTHER